Capital One (COF) CEO exercises 53,487 options; owns 4,001,228 sh
Capital One Financial (COF) reported insider activity by a director and officer (Chairman and CEO).
Rhea-AI Filing Summary
Capital One Financial (COF) reported insider activity by a director and officer (Chairman and CEO). On 11/04/2025, the insider exercised 53,487 stock options at an exercise price of $63.73 and executed multiple open‑market sales the same day at weighted average prices across disclosed ranges.
The sales were executed under a Rule 10b5‑1 trading plan entered on May 13, 2025. Following these transactions, the insider beneficially owned 4,001,228 shares directly. The exercised options were originally exercisable since 02/15/2019 and carry an expiration date of 02/03/2026. Reported sale price ranges spanned from $217.56 to $221.94, with line‑item weighted averages disclosed.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options | 53,487 | $0.00 | $0.00 |
| Exercise | Common Stock | 53,487 | $63.73 | $3.41M |
| Sale | Common Stock | 2,100 | $218.07 | $458K |
| Sale | Common Stock | 6,102 | $219.07 | $1.34M |
| Sale | Common Stock | 5,679 | $220.23 | $1.25M |
| Sale | Common Stock | 34,437 | $221.04 | $7.61M |
| Sale | Common Stock | 5,169 | $221.75 | $1.15M |
| Sale | Common Stock | 3,881 | $218.47 | $848K |
| Sale | Common Stock | 4,389 | $219.31 | $963K |
| Sale | Common Stock | 16,347 | $220.65 | $3.61M |
| Sale | Common Stock | 25,383 | $221.29 | $5.62M |
Footnotes (10)
- F1. This transaction was executed pursuant to a trading plan entered into by the reporting person on May 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.56 to $218.55. Information regarding the number of shares sold at each price will be provided upon request.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.56 to $219.47. Information regarding the number of shares sold at each price will be provided upon request.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.56 to $220.49. Information regarding the number of shares sold at each price will be provided upon request.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.60 to $221.54. Information regarding the number of shares sold at each price will be provided upon request.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.60 to $221.94. Information regarding the number of shares sold at each price will be provided upon request.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.89 to $218.87. Information regarding the number of shares sold at each price will be provided upon request.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.89 to $219.77. Information regarding the number of shares sold at each price will be provided upon request.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.95 to $220.94. Information regarding the number of shares sold at each price will be provided upon request.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.97 to $221.94. Information regarding the number of shares sold at each price will be provided upon request.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did COF report on this Form 4?
Was the COF insider trading under a Rule 10b5-1 plan?
What were the sale price ranges for the COF stock sold?
What are the key terms of the exercised COF options?
What is the transaction date shown in the COF Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.